Do you want to read an article? Please log in or register.
Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study
Type 1 DiabetesPediatric Diabetes
COMMENTED
Related content
COMMENTED
Type 1 DiabetesPediatric Diabetes
Gluten Intake and Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in Children at Increased Risk of the Disease: The Diabetes Autoimmunity Study in the Young (DAISY)
Diabetes Care.
Lund-Blix NA, Dong F, Mårild K, Seifert J, Barón AE, Waugh KC, Joner G, Størdal K, Tapia G, Stene LC, Johnson RK, Rewers MJ, Norris JM
doi: 10.2337/dc18-2315.
COMMENTED
Type 1 Diabetes
Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes: the TRIGR nested case-control ancillary study
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetologia.
Miettinen ME, Niinistö S, Erlund I, Cuthbertson D, Nucci AM, Honkanen J, Vaarala O, Hyöty H, Krischer JP, Knip M, Virtanen SM, TRIGR Investigators
doi: 10.1007/s00125-019-05077-4.
COMMENTED
Diabetes - GeneralType 1 Diabetes
Plasma Metabolome and Circulating Vitamins Stratified Onset Age of an Initial Islet Autoantibody and Progression to Type 1 Diabetes: the TEDDY Study
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes
Li Q, Liu X, Yang J, Erlund I, Lernmark Å, Hagopian W, Rewers M, She JX, Toppari J, Ziegler AG, Akolkar B, Krischer JP, TEDDY Study Group.
doi: 10.2337/db20-0696
Type 1 DiabetesType 2 Diabetes
Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
Diabetes Care.
Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Dolan LM, Marcovina S, Linder B, Liese AD, Pop-Busui R, Feldman EL
doi: 10.2337/dc17-0179.
RECOMMENDED
Type 1 DiabetesPediatric Diabetes
Distinct Growth Phases in Early Life Associated With the Risk of Type 1 Diabetes: The TEDDY Study
★ 1
Recommended by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care.
Liu X, Vehik K, Huang Y, Larsson HE, Toppari J, Ziegler AG, She JX, Rewers M, Hagopian WA, Akolkar B, Krischer JP, TEDDY Study Group.
doi: 10.2337/dc19-1670.
Type 2 Diabetes
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study
Diabetologia.
Harris K, Oshima M, Sattar N, Würtz P, Jun M, Welsh P, Hamet P, Harrap S, Poulter N, Chalmers J, Woodward M
doi: 10.1007/s00125-020-05162-z.
Type 1 DiabetesType 2 DiabetesDiabetic Complications
Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes
Diabetes Care.
Potier L, Roussel R, Marre M, Bjornstad P, Cherney DZ, El Boustany R, Fumeron F, Venteclef N, Gautier JF, Hadjadj S, Mohammedi K, Velho G
doi: 10.2337/dc19-1062.
COMMENTED
Glycemic Control
Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
Diabetes Care.
Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG
doi: 10.2337/dc18-0287.
Type 2 Diabetes
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)
Lancet Diabetes Endocrinol.
Maddaloni E, Coleman RL, Agbaje O, Buzzetti R, Holman RR
doi: 10.1016/S2213-8587(20)30003-6.